Novartis To Alert EU Doctors About Liver Failure Deaths In Zolgensma Patients

 
• By Vibha Sharma

The European Medicines Agency’s pharmacovigilance committee has reviewed the updated advice that EU prescribers will get on enhanced monitoring of spinal muscular atrophy patients treated with Zolgensma following fatal cases of acute liver failure.

Expensive medicine in the world. Onasemnogene Abeparvovec-Xioi Zolgensma, sold under the brand name Zolgensma with several syringes.
Zolgensma Is Given As A One-Time Infusion To SMA Patients • Source: Shutterstock

More from Europe

More from Geography